CNMD News & Events

CONMED "announced the appointment of John E. Gallagher as Chief Financial Officer, effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. Mr. Gallagher brings nearly three decades of financial experience to CONMED, leading corporate finance, treasury, investor relations, financial planning and analysis, accounting, business performance management, and capital markets activities across public healthcare and industrial companies."

Conmed announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors, effective July 1, 2026. Martin will serve as a member of the Audit Committee and the Strategy Committee, and Mirviss will serve as a member of the Compensation Committee and the Corporate Governance and Nominating Committee. In connection with these appointments, CONMED is increasing the size of its Board to include a total of nine directors.